Return to search

HotSpot Therapeutics fetches $65m Series B

Boston-based HotSpot Therapeutics, Inc, a biotechnology company, has raised $65 million in Series B financing.

Boston-based HotSpot Therapeutics, Inc, a biotechnology company, has raised $65 million in Series B financing. S.R. One Limited led the round with participation from other investors that included Tekla Capital Management, MRL Ventures Fund, Solasta Ventures, Brace Pharma, Atlas Venture and Sofinnova Partners.

Source: Press Release